These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Oral H; Fisher SG; Fay WP; Singh SN; Fletcher RD; Morady F Am J Cardiol; 1999 Feb; 83(3):388-91. PubMed ID: 10072229 [TBL] [Abstract][Full Text] [Related]
4. The origin of proinflammatory cytokines in patients with idiopathic dilated cardiomyopathy. Chang HJ; Chung J; Choi BJ; Choi TY; Choi SY; Yoon MH; Hwang GS; Shin JH; Tahk SJ; Choi BI J Korean Med Sci; 2003 Dec; 18(6):791-6. PubMed ID: 14676433 [TBL] [Abstract][Full Text] [Related]
5. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. Testa M; Yeh M; Lee P; Fanelli R; Loperfido F; Berman JW; LeJemtel TH J Am Coll Cardiol; 1996 Oct; 28(4):964-71. PubMed ID: 8837575 [TBL] [Abstract][Full Text] [Related]
6. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy. Mocelin AO; Issa VS; Bacal F; Guimarães GV; Cunha E; Bocchi EA Eur J Heart Fail; 2005 Aug; 7(5):869-73. PubMed ID: 16043406 [TBL] [Abstract][Full Text] [Related]
7. Association of lipoproteins with cytokines and cytokine receptors in heart failure patients. Differences between ischaemic versus idiopathic cardiomyopathy. Conraads VM; Bosmans JM; Schuerwegh AJ; De Clerck LS; Bridts CH; Wuyts FL; Stevens WJ; Vrints CJ Eur Heart J; 2003 Dec; 24(24):2221-6. PubMed ID: 14659774 [TBL] [Abstract][Full Text] [Related]
8. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Munger MA; Johnson B; Amber IJ; Callahan KS; Gilbert EM Am J Cardiol; 1996 Apr; 77(9):723-7. PubMed ID: 8651123 [TBL] [Abstract][Full Text] [Related]
9. [Activation and role of the tumor necrosis factor-alpha in congestive heart failure]. Bachetti T; Comini L; Agnoletti L; Gaia G; Milanesi B; Curello S; Corti A; Ferrari R; Visioli O Cardiologia; 1996 Apr; 41(4):343-7. PubMed ID: 8674103 [TBL] [Abstract][Full Text] [Related]
10. Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy. Vanderheyden M; Paulus WJ; Voss M; Knuefermann P; Sivasubramanian N; Mann D; Baumgarten G Heart; 2005 Jul; 91(7):926-31. PubMed ID: 15958363 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy. Adamopoulos S; Parissis JT; Georgiadis M; Karatzas D; Paraskevaidis J; Kroupis C; Karavolias G; Koniavitou K; Kremastinos DT Am Heart J; 2002 Aug; 144(2):359-64. PubMed ID: 12177657 [TBL] [Abstract][Full Text] [Related]
12. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Lommi J; Pulkki K; Koskinen P; Näveri H; Leinonen H; Härkönen M; Kupari M Eur Heart J; 1997 Oct; 18(10):1620-5. PubMed ID: 9347273 [TBL] [Abstract][Full Text] [Related]
13. [Cytokines and remodeling of the heart in patients with congestive heart failure]. Jołda-Mydłowska B; Salomon P Pol Arch Med Wewn; 2003 Jan; 109(1):23-33. PubMed ID: 12879763 [TBL] [Abstract][Full Text] [Related]
14. Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity. Parissis JT; Adamopoulos SN; Venetsanou KF; Karas SM; Kremastinos DT J Interferon Cytokine Res; 2003 Jun; 23(6):329-33. PubMed ID: 12859859 [TBL] [Abstract][Full Text] [Related]
15. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Fukunaga T; Soejima H; Irie A; Sugamura K; Oe Y; Tanaka T; Nagayoshi Y; Kaikita K; Sugiyama S; Yoshimura M; Nishimura Y; Ogawa H Am J Cardiol; 2007 Aug; 100(3):483-8. PubMed ID: 17659933 [TBL] [Abstract][Full Text] [Related]
16. Soluble tumor necrosis factor receptor levels identify a subgroup of heart failure patients with increased cardiomyocyte apoptosis. Saraste A; Voipio-Pulkki LM; Heikkilä P; Laine P; Nieminen MS; Pulkki K Clin Chim Acta; 2002 Jun; 320(1-2):65-7. PubMed ID: 11983202 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure. Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Rauchhaus M; Koloczek V; Volk H; Kemp M; Niebauer J; Francis DP; Coats AJ; Anker SD Int J Cardiol; 2000; 76(2-3):125-33. PubMed ID: 11104867 [TBL] [Abstract][Full Text] [Related]
19. Relation of cardiac sympathetic innervation to proinflammatory cytokine levels in patients with heart failure secondary to idiopathic dilated cardiomyopathy. Parthenakis FI; Patrianakos A; Prassopoulos V; Papadimitriou E; Nikitovic D; Karkavitsas NS; Vardas PE Am J Cardiol; 2003 May; 91(10):1190-4. PubMed ID: 12745101 [TBL] [Abstract][Full Text] [Related]
20. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Milani RV; Mehra MR; Endres S; Eigler A; Cooper ES; Lavie CJ; Ventura HO Chest; 1996 Oct; 110(4):992-5. PubMed ID: 8874257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]